Recent Comments

Comment RSS

Nicardipine Hydrochloride Injection for short-term treatment of hypertension launched

19. November 2009 00:00

Caraco Pharmaceutical Laboratories, Ltd. (NYSE Amex: CPD) has launched Nicardipine Hydrochloride Injection immediately following Sun Pharma's final approval from the US Food and Drug Administration (FDA).

Nicardipine Hydrochloride Injection is indicated for the short-term treatment of hypertension when oral therapy is not feasible or not desirable. These Nicardipine Hydrochloride Injections are available as 25 mg/10ml single use ampuls containing 2.5 mg/ml of the drug, and have annual sales of approximately USD 170 million in the US.

SOURCE Caraco Pharmaceutical Laboratories, Ltd.

Posted in: Pharmaceutical News

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.

Add comment



(Will show your Gravatar icon)
  Country flag

biuquote
  • Comment
  • Preview
Loading



News-Medical.Net provides this medical information service in accordance with these terms and conditions. Please note that medical information found on this website is designed to support, not to replace the relationship between patient and physician/doctor and the medical advice they may provide.